JPRN-UMIN000046999已完成Unknown
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients - Effectiveness of BNT162b2 vaccine in Japanese hemodialysis patients
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 185
研究概览
简要总结
The anti-SARS-CoV-2 IgG antibody positivity rate after BNT162b2 vaccine administration was 181/185 = 97.8% in the hemodialysis patients.The median antibody titer in hemodialysis patients was 2728.7 AU/mL, with a quartile range of 1024.2-7688.2 AU/mL.Adverse events associated with vaccine administration were mild.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with no history of COVID-19
研究者
相似试验
已完成
不适用
Humoral response after BNT162b2 vaccination in hemodialysis patientsChronic renal failure during hemodialysisJPRN-UMIN000047032Fujita Memorial Hospital294
已完成
不适用
Covid-19 Vaccine Response in Elderly SubjectsCovid19 VaccineNCT04760704University Hospital, Lille264
Unknown
4 期
Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in ChildrenJapanese EncephalitisNCT01954810Khon Kaen University88
已完成
不适用
Antibody response after vaccination with Japanese Hepatitis A Vaccine and evaluation of the booster programHepatitis AJPRN-UMIN000013624Tokyo Medical University30
尚未招募
不适用
Immunogenicity of 2 dose regimen of BNT162b2 mRNA vaccine in Thai children aged 6 months to 4 years following COVID 19 (COVID-19)Prevention of COVID-19 with 2-dose mRNA vaccine among healthy Children 6 month to 4 years who had COVID-19 infectionSARS-CoV-2, mRNA vaccine, Infant, Children, Immunogenicity, ReactogenicityTCTR20221018008Ratchadaphisek Sompoch Research Fund80